Loading clinical trials...
Loading clinical trials...
A Single-blind, Placebo-controlled, 2-period, Fixed Sequence Study to Determine the Effects of Coadministration of Fostamatinib 100 mg Twice Daily on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Subjects
Conditions
Interventions
fostamatinib
Microgynon® 30 (Oral contraceptive)
+1 more
Locations
1
United Kingdom
Research Site
London, United Kingdom
Start Date
March 1, 2011
Primary Completion Date
November 1, 2011
Completion Date
November 1, 2011
Last Updated
February 20, 2012
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions